Ethicon study reports bariatric surgery as effective treatment for Asian Indian type II patients Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon said it presented data from a study supporting bariatric surgery as a better treatment option than medical therapy and lifestyle management for obese Asian Indian patients with inadequately controlled type 2 diabetes. Data came from […]
Clinical Trials
Oversight board OKs trial for Echo Therapeutics non-invasive CGM
Echo Therapeutics (NSDQ:ECTE) said today it won Institutional Review Board approval to expand testing of its non-invasive continuous glucose monitor, which can now include both pediatric and adult subjects. The Iselin, N.J.-based company is developing a non-invasive, wireless CGM for use in the outpatient diabetes market and the fitness, weight loss and personal lifestyle wearable-health space. […]
Medtronic touts ‘closed-loop’ insulin management system | American Diabetes Assn. 2016 Scientific Sessions
Medtronic touts ‘closed-loop’ insulin management system In its latest step on the quest to create an artificial pancreas, Medtronic (NYSE:MDT) said a pivotal trial showed that its hybrid “closed-loop” insulin management system proved safe and effective. The HCL system is designed to automatically control blood glucose levels with minimal input or supervision from patients or […]
Study backs laser prostate ablation with Medtronic’s Artemis
Laser ablation may be a feasible and safe treatment option for men with intermediate risk prostate cancer, according to a new study published in the Journal of Urology. The treatment operates using magnetic resonance imaging to guide a laser fiber into a cancerous tumor in the prostate to destroy the tissue with extreme heat. The study […]
Medtronic touts shorter stays, less retreats with cryoablation for treating paroxysmal AF
Medtronic (NYSE:MDT) today touted data from its Fire and Ice clinical trial indicating lower rates of repeat procedures and shorter hospital stays for patients with paroxysmal atrial fibrillation treated with its Arctic Front cryoballoon when compared to those treated with radiofrequency ablation catheters. Data from the secondary analysis of the study comparing the company’s Arctic Front […]
Study: Lower major complication risk with Medtronic’s Micra compared to conventional pacers
Medtronic (NYSE:MDT) today released new results from a clinical trial of its leadless Micra transcatheter pacing system, touting significantly reduced major complication risks compared to conventional pacing systems. The Micra transcatheter pacing system, which at 1/10th the size of a conventional pacemaker is roughly the size of a large vitamin, is designed to be implanted via […]
Medtronic launches Valiant Evo TAA device trial
Medtronic (NYSE:MDT) said today it enrolled the 1st patient in a trial of its Valiant Evo thoracic stent graft system designed for the minimally invasive repair of descending thoracic aortic aneurysms. The 1st procedure in the trial was performed recently at the Univeristy of Texas Health Science Center at Houston by principal investigator Ali Azizzadeh, […]
IBM Watson Health to aid in matching cancer patients to clinical trials
IBM‘s (NYSE:IBM) famed Watson artificial intelligence platform will be put to use to help match cancer patients with clinical trials. The Armonk, N.Y.-based technology giant said Froedtert & the Medical College of Wisconsin Network will adopt the Watson technology for this purpose in a project set to begin this fall. Froedtert/MCW Cancer Network are among the 1st cancer […]
Milestone Scientific touts CompuFlo trial completion, plans FDA submission
Milestone Scientific‘s (OTC:MLSS) said today it completed the pivotal study of its CompuFlo epidural computer controlled system, investigating the safety and efficacy of the epidural space verification of the system. The 400-patient, multicenter pivotal Compass study looked to compare treatment with the CompuFlo device against the current standard of care for patients undergoing pain management and […]
Ocular Therapeutix shares plummet as 2nd Phase III misses primary endpoint
Ocular Therapeutix (NSDQ:OCUL) today saw shares dive over 40% after reporting the 2nd phase 3 clinical trial of its Dextenza drug-device combination failed to meet its primary endpoint. Bedford, Mass.-based Ocular Therapeutix’s Dextenza, formerly known as OTX-DP, is designed to deliver sustained dosage of dexamethasone over 4 weeks using a hydrogel plug inserted into a tear […]
Intact Vascular launches clinical trial of Tack system
Intact Vascular said today it launched the Tack Optimized Balloon Angioplasty III clinical trial investigating its Tack endovascular system along with Medtronic‘s (NYSE:MDT) Admiral drug-coated angioplasty balloon for treating peripheral arterial disease. The Tack endovascular system is designed to repair dissections that occur as a complication of balloon angioplasty. The system allows operating physicians to repair […]